TMO

Thermo Fisher Scientific, Inc. New York Stock Exchange
$496.51
Open: $492.21 High: $498.43 Low: $487.01 Close: $496.201
Range: 2021-06-23 - 2021-06-24
Volume: 2,056,560
Market: Open
Powered by Finage Stock APIDelayed data
TMO
Thermo Fisher Scientific, Inc. 168 Third Avenue Waltham MA, 2451 http://www.thermofisher.com
Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.
  • CEO: Marc N. Casper
  • Employees: 70,000
  • Sector: Healthcare
  • Industry: Medical Diagnostics & Research
TMO News
Latest news about the TMO
  • Agilent (A) Expands Presence in LC Market With New Systems

    Agilent (A) expands its Bio Liquid Chromatography solutions portfolio with three new systems to fulfil the needs of biopharma industry.

    View More →
  • Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today

    Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.

    View More →
  • Thermo Fisher (TMO) Invites Applications for Oncomine Program

    Thermo Fisher (TMO) to review research proposals eligible for the Oncomine Clinical Research Grant program.

    View More →
  • Thermo Fisher's (TMO) New Launch Boosts Preclinical Development

    Thermo Fisher's (TMO) enhanced Quick to Clinic solution provides balance of speed and quality to accelerate and advance DNA to Investigational New Drug in as less as 13 months.

    View More →
  • Is Thermo Fisher Scientific Inc. (TMO) A Good Stock To Buy?

    Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don’t make them change their opinion towards a company. This time it may be different. The coronavirus pandemic destroyed the high correlations among major industries and asset classes. We are […]

    View More →
  • U.S. senator slams Apple, Amazon, Nike, for enabling forced labor in China

    A U.S. senator on Thursday slammed American companies, including Amazon.com Inc, Apple Inc and Nike Inc, for turning a blind eye to allegations of forced labor in China, arguing they were making American consumers complicit in Beijing's repressive policies. Speaking at a Senate Foreign Relations Committee hearing on China's crackdown on Uyghurs and other Muslim minorities in its western Xinjiang region, Republican Senator Marco Rubio said many U.S. companies had not woken up to the fact that they were "profiting" from the Chinese government's abuses.

    View More →
  • Thermo Fisher Scientific to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference on June 10, 2021

    Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 9:40 a.m. (EDT).

    View More →
  • Thermo Fisher (TMO) End Markets Rebound as COVID-19 Cases Drop

    In academic and government end markets, Thermo Fisher (TMO) grows on robust customer activity globally.

    View More →
  • 4 Stocks to Watch in the Growing Nanotechnology Market

    Watch out for names like Onto Innovation (ONTO), DuPont de Nemours (DD), Thermo Fisher Scientific (TMO) and International Business Machines (IBM) as the nanotechnology market continues to grow.

    View More →
  • The Zacks Analyst Blog Highlights: JPMorgan, PayPal, Thermo Fisher Scientific, PepsiCo, McDonald's and Canadian National Railway

    The Zacks Analyst Blog Highlights: JPMorgan, PayPal, Thermo Fisher Scientific, PepsiCo, McDonald's and Canadian National Railway

    View More →
  • Top Analyst Reports for JPMorgan, PayPal & Thermo Fisher

    Top Analyst Reports for JPMorgan, PayPal & Thermo Fisher

    View More →
  • 3 Medical Diagnostics Stocks in Focus on Long-Term Potential

    MedTech testing stocks like Quest Diagnostics Incorporated (DGX), Thermo Fisher Scientific, Inc. (TMO) and Laboratory Corporation of America Holdings (LH) are likely to survive post-pandemic.

    View More →
  • Thermo Fisher Scientific (TMO) Dips More Than Broader Markets: What You Should Know

    Thermo Fisher Scientific (TMO) closed at $445.33 in the latest trading session, marking a -0.86% move from the prior day.

    View More →
  • Charts Warm Up to Thermo Fisher Scientific

    The name is on Jim Cramer's buy-the-dip list, so let's check it out and see where traders could buy strength.

    View More →
  • Buy-the-Dip Candidates: Cramer Likes Abbott Labs, Danaher, Thermo Fisher

    These stocks that fell in the past week could be buy-the-dip opportunities. Recent losers include Okta, Match Group, Procter & Gamble, and more.

    View More →
  • Moderna Inks COVID-19 Vaccine Production Agreement with Lonza

    Biotechnology company Moderna Inc. (MRNA) has inked an additional drug substance manufacturing agreement with Lonza. Per the terms of the agreement, a new production line will be set up at Lonza’s Geleen facility in the Netherlands, which will supply 300 million doses of Moderna’s booster variant vaccine candidate which is yet to receive approval. Moderna also has a drug substance supply agreement with ROVI in Spain and expects to supply about 600 million doses each year in the E.U. Both of thes

    View More →
  • Moderna (MRNA) Files for Full Approval of COVID-19 Vaccine

    Moderna (MRNA) seeks full approval for its COVID-19 vaccine, mRNA-1273, in adults with initiation of rolling submission of a BLA. The company also boosts manufacturing capacity for the vaccine.

    View More →
  • Moderna Taps Thermo Fisher to Help Scale Up COVID-19 Vaccine Production

    Moderna Inc (NASDAQ: MRNA) entered into an agreement with Thermo Fisher Scientific Inc (NYSE: TMO) for manufacturing and packaging its COVID-19 vaccine, as Moderna looks to scale up production. Thermo Fisher Scientific will provide fill-finish, labeling, and packaging services for Moderna’s mRNA vaccine at Thermo Fisher’s commercial manufacturing site in Greenville, North Carolina. Moderna said the latest agreement would “support the production of hundreds of millions of doses,” and production i

    View More →
  • Moderna partners with Thermo Fisher to scale up COVID-19 vaccine production

    Moderna Inc said on Tuesday it had entered into an agreement with Thermo Fisher Scientific for manufacturing and packaging its COVID-19 vaccine, as the U.S. vaccine maker looks to scale up production. Under the terms, Moderna said Thermo Fisher's commercial manufacturing site in Greenville, North Carolina will be used to provide fill/finish manufacturing services and supply packaging for hundreds of millions of doses of the vaccine. "The addition of Thermo Fisher to our network will support our efforts to scale up our manufacturing ability," Moderna's chief technical operations and quality officer, Juan Andres, said in a statement.

    View More →
  • Moderna, Thermo Fisher ink deal to make COVID-19 vaccine

    Moderna Inc. said late Tuesday it has hammered out an agreement with Thermo Fisher Scientific for the manufacturing, labeling and packing of Moderna's COVID-19 vaccine at a Thermo Fisher plant in North Carolina. The agreement aims "to leverage manufacturing capacity to continue to drive global supply of vaccines," the company said. The production of "hundreds of millions" of doses of the vaccine will start in the third quarter, Moderna said. "Thermo Fisher has been a critical partner in supplyin

    View More →